Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
作者信息
Lee H J, Amidon G L
机构信息
Alkermes, Inc., Cambridge, MA 02139, USA.
出版信息
NIDA Res Monogr. 1995;154:86-106.
PMID:8606751
Abstract
摘要
相似文献
1
Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
NIDA Res Monogr. 1995;154:86-106.
2
Oral biodrug delivery using cell-penetrating peptide.利用穿透肽进行口服生物药物传递。
Adv Drug Deliv Rev. 2012 May 1;64(6):531-9. doi: 10.1016/j.addr.2011.12.014. Epub 2012 Jan 4.
3
Microemulsions for improved peptide absorption from the gastrointestinal tract.
Methods Find Exp Clin Pharmacol. 1991 Apr;13(3):205-20.
4
Intestinal metabolism and absorption of cholecystokinin analogs in rats.
Biochem Biophys Res Commun. 2002 Apr 5;292(3):632-8. doi: 10.1006/bbrc.2002.6718.
5
Multifunctional matrices for oral peptide delivery.用于口服肽递送的多功能基质。
Crit Rev Ther Drug Carrier Syst. 2001;18(5):459-501.
6
[Methodologies for regulation of intestinal absorption of biologically active peptides].[调节生物活性肽肠道吸收的方法]
Nihon Rinsho. 1998 Mar;56(3):589-94.
7
Delivery systems for biopharmaceuticals.
J Pharm Pharmacol. 1992 Feb;44 Suppl 1:186-90.
8
Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.肽类药物口服吸收的体外和体内模型的相关性
Amino Acids. 2008 Jun;35(1):233-41. doi: 10.1007/s00726-007-0581-5. Epub 2007 Aug 30.
9
The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.[D-丙氨酸2，D-亮氨酸5]脑啡肽口服给药后酶抑制剂和吸收部位对大鼠的影响。
Biopharm Drug Dispos. 2002 May;23(4):131-41. doi: 10.1002/bdd.302.
10
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.亚微米级壳聚糖包衣脂质体用于口服肽类药物的有效性
Int J Pharm. 2005 Oct 13;303(1-2):160-70. doi: 10.1016/j.ijpharm.2005.06.028.
引用本文的文献
1
Superporous polyacrylate/chitosan IPN hydrogels for protein delivery.超多孔聚丙烯酸酯/壳聚糖 IPN 水凝胶用于蛋白质递送。
J Mater Sci Mater Med. 2011 Nov;22(11):2467-75. doi: 10.1007/s10856-011-4422-4. Epub 2011 Sep 8.
Zotero 插件